InvestorsHub Logo
Followers 30
Posts 2229
Boards Moderated 0
Alias Born 12/13/2016

Re: None

Saturday, 05/06/2017 12:53:24 AM

Saturday, May 06, 2017 12:53:24 AM

Post# of 474315
FELLOW AVXL LONGS, Here is a response I just received from the RETT Syndrome Foundation in answer to a question I asked as to the Status of the ANAVEX 2-73 trial. It is somewhat confusing in that the responder says it is on schedule for this Fall but then says it will be ready to go as soon as ANAXEX has completed FDA prerequisites. I'll clarify the drivers for the start of the trial with them by email this weekend.

"
Hi ----,

Thanks for reaching out about Phase 2 of the Anavex 2-73 clinical trial. The design of the trial is on schedule and Anavex Life Sciences, Corp. is trying their best to expedite the process. As of today, they are still on schedule to meet the launch in Fall, 2017. As soon as they have cleared all the necessary steps with the IRBs and FDA, they will begin. Rettsyndrome.org will announce immediately after they are cleared. Please continue to check with us on the status. Thank you.

Amanda Haskamp
Database Administrator
4600 Devitt Drive Cincinnati, OH 45246
Direct 513-454-0030; Main 1-800-818-7388; Fax 513-874-2520"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News